Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03925792
Other study ID # PSY006
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2019
Est. completion date December 31, 2019

Study information

Verified date March 2020
Source Chinese University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will examine the feasibility and efficacy of lifestyle medicine for the enhancement of psychological wellness in police officers. The integrative lifestyle intervention is based on the "Healthy Body Healthy Mind (HBHM)" programme developed by the University of Melbourne. It includes lifestyle psychoeducation, physical activity, nutrition and diet, relaxation/ mindfulness, and sleep. These components are weaved with psychological elements such as stress management, cognitive restructuring, motivational interviewing, and goal setting strategies that are led by clinical psychologists. While lifestyle medicine has been recognised for centuries a a mean to improve physical health, the field of lifestyle medicine in the context of mental health is still in its infancy. Nevertheless, there is increasing evidence demonstrating the efficacy of individual components of lifestyle medicine (e.g. diet, physical activities, and sleep) on mood and stress management. With a well-researched lifestyle medicine programme adopted from Australia, the research team of the Chinese University of Hong Kong has customised the intervention protocol to fit the Chinese culture, and has conducted a pilot trial to test the protocol across different communities and work populations. The investigators aim to examine the effectiveness of an integration of multiple lifestyle adjustments on psychological wellness from a holistic body-mind perspective. Acknowledging that police officers are one of hte work populations with stressful work nature, it is in a hope that lifestyle medicine would be effective to facilitate stress coping and enhance the psychological wellness of police officers in the long run.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date December 31, 2019
Est. primary completion date November 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Hong Kong residents aged = 18 years;

2. Cantonese language fluency;

3. Patient Health Questionnaire (PHQ-9) score = 10; and

4. Willingness to provide informed consent and comply with the trial protocol.

Exclusion Criteria:

1. Pregnancy;

2. Have suicidal ideation with PHQ-9 item 9 score = 2 (referral information to professional services will be provided to those who endorsed items on suicidal ideation);

3. Using medication or psychotherapy for depression;

4. Having unsafe conditions and are not recommended for exercising or a change in diet by physicians; and

5. Have major psychiatric, medical or neurocognitive disorders that make participation infeasible or interfere with the adherence to the lifestyle intervention.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Lifestyle Medicine
diet, sleep, exercise and mindfulness

Locations

Country Name City State
Hong Kong The Chinese University of Hong Kong Hong Kong

Sponsors (3)

Lead Sponsor Collaborator
Chinese University of Hong Kong University of Melbourne, University of Western Sydney

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the Patient Health Questionnaire (PHQ-9) The PHQ-9, a 20-item questionnaire used for screening, diagnosing, monitoring and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day).
PHQ-9 scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe and severe depression respectively.
Baseline, 1-week post-treatment and 12-week post treatment
Secondary Change in Depression Anxiety Stress Scales (DASS-21) DASS-21 is a 21-items scales, comprises three sub-scales which measures the negative emotional states of depression, anxiety, and stress, over the past week. The DASS is based on a dimensional rather than a categorical conception of psychological disorder, thus it has no direct implications for the allocation of patients to discrete diagnostic categories. However, recommended cutoffs for conventional severity labels (normal, moderate, severe) are given in the DASS Manual.
Depression Anxiety Stress Normal 0-9 0-7 0-14 Mild 10-13 8-9 15-18 Moderate 14-20 10-14 19-25 Severe 21-27 15-19 26-33 Ex. Severe 28+ 20+ 34+
Baseline, 1-week post-treatment and 12-week post treatment
Secondary Change in Insomnia Severity Index (ISI) ISI is a 7-item scale designed to evaluate perceived insomnia severity. Ratings on the 5-point Likert scale are obtained on the perceived severity of sleep-onset, sleep-maintenance, early morning awakening problems, satisfaction with current sleep pattern, interference with daily functioning, noticeably of impairment attributed to the sleep problem, and level of distress caused by the sleep problem.
Total score categories: 0-7 indicates no clinically significant insomnia, 8-14 refers to subthreshold insomnia,15-21 represents clinical insomnia (moderate severity), and 22-28 is clinical insomnia (severe).
Baseline, 1-week post-treatment and 12-week post treatment
Secondary Brief Resilience Scale The BRS, originally developed by Smith and colleagues (2008), is a 6-item questionnaire rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). Higher scores represent higher level of psychological resilience. The Chinese version of the test validated by Lai & Yue (2014) has demonstrated good psychometric properties (Cronbach's alpha > .72) and were comparable to the original version developed by Smith and colleagues.
Total score divided by 6 and to be categorized: 1.00-2.99 indicates low resilience; 3.00-4.30 indicates normal resilience and 4.31-5.00 indicated high resilience.
Baseline, 1-week post-treatment and 12-week post treatment
Secondary Short Form (Six-Dimension) Health Survey (SF-6D) The SF-6D is a preference-based single index measure of health. A six-digit number represents each SF-6D health state, each digit denotes the level of one of six SF-6D dimensions: physical functioning, role limitation, social functioning, bodily pain, mental health, and vitality. The SF-6D index, scores from 0.0 (worst health state) to 1.0 (best health state). Baseline, 1-week post-treatment and 12-week post treatment
Secondary Health-Promoting Lifestyle Profile (HPLP II) The 52-item HPLPII is composed of a total scale and six subscales to measure behaviors in the theorized dimensions of health-promoting lifestyle: spiritual growth, interpersonal relations, nutrition, physical activity, health responsibility, and stress management.
Items are scored as Never (N) = 1, Sometimes (S)= 2, Often (O) = 3, Routinely (R) = 4 A score for overall health-promoting lifestyle is obtained by calculating a mean of the individual's responses to all 52 items; six subscale scores are obtained similarly by calculating a mean of the responses to subscale items. The use of means rather than sums of scale items is recommended to retain the 1 to 4 metric of item responses and to allow meaningful comparisons of scores across subscales.
Baseline, 1-week post-treatment and 12-week post treatment
Secondary Change in Sheehan Disability Scale (SDS) SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life. Representation of scores in terms of functional impairment: 0: not at all, 1-3: mildly, 4-6: moderately, 7-9: markedly, 10: extremely. Baseline, 1-week post-treatment and 12-week post treatment
Secondary Physical activity (Fitbit Surge Fitness Superwatch) The Fitbit Surge, a commercially available accelerometer-based activity tracker, is used to examine patterns of physical activity and heart rate, objectively. Baseline, 1-week post-treatment and 12-week post treatment
Secondary Change in Credibility-Expectancy Questionnaire (CEQ) The 6-item CEQ yielded ratings of treatment credibility, acceptability/satisfaction, and expectations for success. Baseline, 1-week post-treatment
See also
  Status Clinical Trial Phase
Completed NCT04429828 - COVID-19 Psychological Wellbeing for Healthcare Students N/A
Completed NCT05966844 - Golden Age: Virtual Reality and Mindfulness N/A
Completed NCT06334328 - Virtual Reality-based Mindful Movement Therapy for Seniors N/A